powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1093210171
John Gilboy
MD
Pulmonary Disease
South Portland,
ME
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
Final MIPS score
97.9
Quality
83.3
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.97%
APM Entity
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (5)
CCN 200008
Hospital
CCN 200009
Hospital
CCN 200039
Hospital
CCN 201315
Hospital
CCN 301307
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
104
Beneficiaries
—
Total drug cost
$44K
Distinct drugs
5
Brand share
72.1%
Top prescribed drugs
Fluticasone/Umeclidin/Vilanter
46 claims
Umeclidinium Bromide
15 claims
Omeprazole
15 claims
Umeclidinium Brm/Vilanterol Tr
14 claims
Prednisone
14 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
85
Unique beneficiaries
—
Total services
99
Distinct HCPCS
4
Medicare payment
$12K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 49 Pulmonary Disease providers in ME — bottom quintile (cohort median 523).